Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). | PLoS Genet | 2023 | 36595552 | PubTator, text mining | PubMed |
| Novel biological insights revealed from the investigation of multiscale genome architecture. | Comput Struct Biotechnol J | 2023 | 36582436 | PubTator, text mining | PubMed |
| Analysis of endometrial carcinoma TCGA reveals differences in DNA methylation in tumors from Black and White women. | Gynecol Oncol | 2023 | 36580834 | PubTator, text mining | PubMed |
| YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches. | Nat Cancer | 2023 | 36564601 | PubTator, text mining | PubMed |
| Loss of surface transport is a main cellular pathomechanism of CRB2 variants causing podocytopathies. | Life Sci Alliance | 2023 | 36549870 | PubTator, text mining | PubMed |
| Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal Cancer. | Cancer Discov | 2023 | 36520636 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid biomarkers in pediatric brain tumors: A systematic review. | Neoplasia | 2023 | 36516487 | PubTator, text mining | PubMed |
| Peto's paradox revisited: black box vs mechanistic approaches to understanding the roles of mutations and promoting factors in cancer. | Eur J Epidemiol | 2023 | 36512199 | PubTator, text mining | PubMed |
| Nutrition claims influence expectations about food attributes, attenuate activity in reward-associated brain regions during tasting, but do not impact pleasantness. | Brain Behav | 2023 | 36511877 | PubTator, text mining | PubMed |
| Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8+ T cells in osteosarcoma. | Exp Biol Med (Maywood) | 2023 | 36511103 | PubTator, text mining | PubMed |
| Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry. | Clin Cancer Res | 2023 | 36508165 | PubTator, text mining | PubMed |
| Dietary fat intake is associated with insulin resistance and an adverse vascular profile in patients with T1D: a pooled analysis. | Eur J Nutr | 2023 | 36495341 | PubTator, text mining | PubMed |
| Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation. | Clin Cancer Res | 2023 | 36449687 | PubTator, text mining | PubMed |
| Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study. | Cancer Med | 2023 | 36420687 | PubTator, text mining | PubMed |
| Derivation of pancreatic acinar cell carcinoma cell line HS-1 as a patient-derived tumor organoid. | Cancer Sci | 2023 | 36382538 | PubTator, text mining | PubMed |
| Circular RNAs: New layer of complexity evading breast cancer heterogeneity. | Noncoding RNA Res | 2023 | 36380816 | PubTator, text mining | PubMed |
| Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials. | Haematologica | 2023 | 36325893 | PubTator, text mining | PubMed |
| Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. | Mol Cancer Res | 2023 | 36306210 | PubTator, text mining | PubMed |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. | FEBS Open Bio | 2023 | 36282125 | PubTator, text mining | PubMed |
| Neuroinflammation and glial activation in the central nervous system: a metabolic perspective. | Neural Regen Res | 2023 | 36254985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=47